The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The CDC will no longer recommend routine Covid shots for healthy children and pregnant women, Health and Human Services ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

The agency recommends manufacturers update their vaccines to target the JN.1 strain. At the same time, HHS head Robert F.

Just a week after the FDA updated its stance on new COVID-19 | The CDC's recommended immunization schedule no longer includes ...

The move underscores the profound impact HHS Secretary Robert F. Kennedy is exerting on immunizations in the U.S.

The Centers for Disease Control and Prevention will no longer recommend that healthy children and pregnant women receive the COVID-19 vaccine, the Trump administration announced Tuesday. “Last ...

Kennedy Jr. on Tuesday announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. In ...

Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...